Impact of mitochondrial ROS production on diabetic vascular complications

被引:67
作者
Nishikawa, Takeshi [1 ]
Kukidome, Daisuke [1 ]
Sonoda, Kazuhiro [1 ]
Fujisawa, Kazuo [1 ]
Matsuhisa, Takako [1 ]
Motoshima, Hiroyuki [1 ]
Matsumura, Takeshi [1 ]
Araki, Eiichi [1 ]
机构
[1] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Metab Med, Kumamoto 8608556, Japan
基金
日本学术振兴会;
关键词
diabetic complication; reactive oxygen species; mitochondria; 8-hydroxydeoxyguanosine;
D O I
10.1016/j.diabres.2007.01.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular complications are the leading cause of morbidity and mortality in patients with diabetes. Four main molecular mechanisms have been implicated in glucose-mediated vascular disease. There are: glucose-induced activation of protein kinase C (PKC) isoforms; increased formation of glucose-derived advanced glycation end-products (AGE); increased glucose flux through the aldose reductase pathway; and increased production of reactive oxygen species (ROS). Here we demonstrate that hyperglycemia-induced production of ROS is abrogated by inhibitors of mitochondrial metabolism, or by overexpression of uncoupling protein-1 or manganese superoxide dismutase. Normalization of mitochondrial ROS production by each of these agents prevents Glucose-induced activation of PKC, formation of AGE, and accumulation of sorbitol in bovine vascular endothelial cells. We also claim that 8-hydroxydeoxyguanosine, which represents mitochondrial oxidative damage was elevated in patients with either retinopathy, albuminuria or increased intima-media thickness of carotid arteries. These results suggest that hyperglycemia induces mitochondrial ROS production, and which can associate to the pathogenesis of diabetic vascular complications. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:S41 / S45
页数:5
相关论文
共 19 条
[1]   The free radical theory of aging matures [J].
Beckman, KB ;
Ames, BN .
PHYSIOLOGICAL REVIEWS, 1998, 78 (02) :547-581
[2]   Biochemistry and molecular cell biology of diabetic complications [J].
Brownlee, M .
NATURE, 2001, 414 (6865) :813-820
[3]   NERVE-CONDUCTION AND ALDOSE REDUCTASE INHIBITION DURING 5 YEARS OF DIABETES OR GALACTOSEMIA IN DOGS [J].
ENGERMAN, RL ;
KERN, TS ;
LARSON, ME .
DIABETOLOGIA, 1994, 37 (02) :141-144
[4]   Oxidative stress and diabetic vascular complications [J].
Giugliano, D ;
Ceriello, A ;
Paolisso, G .
DIABETES CARE, 1996, 19 (03) :257-267
[5]   AMINOGUANIDINE TREATMENT INHIBITS THE DEVELOPMENT OF EXPERIMENTAL DIABETIC-RETINOPATHY [J].
HAMMES, HP ;
MARTIN, S ;
FEDERLIN, K ;
GEISEN, K ;
BROWNLEE, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11555-11558
[6]   Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor [J].
Ishii, H ;
Jirousek, MR ;
Koya, D ;
Takagi, C ;
Xia, P ;
Clermont, A ;
Bursell, SE ;
Kern, TS ;
Ballas, LM ;
Heath, WF ;
Stramm, LE ;
Feener, EP ;
King, GL .
SCIENCE, 1996, 272 (5262) :728-731
[7]   Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells - Potential role in diabetic nephropathy [J].
Kiritoshi, S ;
Nishikawa, T ;
Sonoda, K ;
Kukidome, D ;
Senokuchi, T ;
Matsuo, T ;
Matsumura, T ;
Tokunaga, H ;
Brownlee, M ;
Araki, E .
DIABETES, 2003, 52 (10) :2570-2577
[8]   Protein kinase C activation and the development of diabetic complications [J].
Koya, D ;
King, GL .
DIABETES, 1998, 47 (06) :859-866
[9]  
Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943
[10]   Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation [J].
Nakamura, S ;
Makita, Z ;
Ishikawa, S ;
Yasumura, K ;
Fujii, W ;
Yanagisawa, K ;
Kawata, T ;
Koike, T .
DIABETES, 1997, 46 (05) :895-899